Ares Financial Consulting’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.62K Buy
57
+45
+375% +$4.33K ﹤0.01% 714
2026
Q2
$1.14K Sell
12
-35
-74% -$3.36K ﹤0.01% 985
2026
Q1
$4.9K Buy
47
+35
+292% +$3.97K ﹤0.01% 685
2025
Q4
$1.21K Buy
+12
New +$1.3K ﹤0.01% 740

Other funds holding CLX

Ares Financial Consulting's CLX Position: Q3 2026 in Review

Ares Financial Consulting increased its Clorox (CLX) stake by 375% in Q3 2026, buying an estimated $4.33K and bringing the position to 57 shares worth $4.62K. The position accounts for ﹤0.01% of the portfolio, ranked #714.

Ares Financial Consulting first reported a position in CLX in Q4 2025 and has held it in 4 quarters since. The position peaked at $4.9K in Q1 2026. 503 funds tracked by Wall St. Rank hold CLX as of Q3 2026.

  • Ares Financial Consulting held 57 shares of Clorox worth $4.62K as of Q3 2026.
  • Ares Financial Consulting bought 45 Clorox shares in Q3 2026, an estimated $4.33K.
  • Clorox made up ﹤0.01% of Ares Financial Consulting's portfolio in Q3 2026, its #714 holding.
  • Ares Financial Consulting first reported a position in Clorox in Q4 2025 and has held it in 4 quarters since.
  • Ares Financial Consulting's Clorox position peaked at $4.9K in Q1 2026.
  • 503 funds tracked by Wall St. Rank held Clorox as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.